Pramodini Kale-Pradhan, Pharm.D., FCCP, FIDSA
Professor (Clinical)
Office Location
EACPHS, Room 4132
Phone
313-577-0824
Department
Pharmacy Practice
Research website
Pramodini Kale-Pradhan, Pharm.D., FCCP, FIDSA
Degrees and Certifications
Degrees
- 1989 - Doctor of Pharmacy, Philadelphia College of Pharmacy and Science
- 1981 - Bachelors of Science - Pharmacy, University of Wisconsin-Madision
Certifications
- 1991 - Fellow in Infectious Diseases and Surgery, The University of Illinois at Chicago-College of Pharmacy
- 1990 - Advanced Resident in Infectious Diseases and Surgery, The University of Illinois at Chicago-College of Pharmacy
Positions and Employment
- 2011-present - Professor (Clinical), Department of Pharmacy Practice
- 2007-present - Clinical Specialist, Infectious Diseases, Ascension St. John Hospital, Detroit, MI
- 2000-2011 - Associate Professor (Clinical), Department of Pharmacy Practice
- 1991-2007 - Clinical Specialist, Surgical Intensive Care, St. John Hospital & Medical Center, Detroit, MI
- 1991-2000 - Assistant Professor (Clinical), Department of Pharmacy Practice
Awards and Honors
- 2023 - Fellow Infectious Diseases Society of America
- 2020 - Faculty Mentor Excellence Award – Teaching Certificate Program Wayne State University
- 2014, 2019, 2022 - Faculty Mentor for Outstanding Student Poster Award in Clinical Sciences
- 2013, 2010 - Preceptor of the Year St. John Hospital and Medical Center LAPP
- 2001 - College of Pharmacy and Allied Health Professions Excellence in Teaching Award
- 2001 - Externship Preceptor of the Year
- 2000 - SMSHP Research Preceptor Award - For the combined Student/Preceptor Research Award
- 1998 - Externship Preceptor of the Year
- 1993 - SMSHP Research Preceptor Award - For the combined Student/Preceptor Research Award
Professional Memberships
- 2014-present,1992–2002- American Association of Colleges of Pharmacy
- 2010-present - Society of Infectious Diseases Pharmacists
- 2007-present - Infectious Diseases Society of America
- 2000-present - Society of Critical Care
- 1990-present - American Colleges of Clinical Pharmacy
- 1982-present - American Society of Hospital Pharmacists
Areas of Expertise
- Gastroenterology
- Infectious diseases
Recent Publications
Invited Book Chapters
- Kale-Pradhan PB and Wilhelm SM. Prebiotics and Probiotics. In Handbook of Non-Prescription Drugs – An Interactive Approach to Self Care 21th Ed., (Invited Chapter) 2024 Major edits made
- McConachie S, Kale-Pradhan P, Wilhelm S. Gastroesophageal Reflux Disease. Pharmacy Library’s Pharmacotherapy First: A Multimedia Learning Resource. Washington, DC: American Pharmacists Association; Feb 2023.
- Kale-Pradhan PB and Wilhelm SM. Prebiotics and Probiotics. In Handbook of Non-Prescription Drugs – An Interactive Approach to Self Care 20th Ed., (Invited Chapter) 2020
- McConachie S, Kale-Pradhan P, Wilhelm S. Gastroesophageal Reflux Disease. Pharmacy Library’s Pharmacotherapy First: A Multimedia Learning Resource. Washington, DC: American Pharmacists Association; 2019.
- McConachie S, Kale-Pradhan P, Wilhelm S. Gastroesophageal Reflux Disease. Pharmacy Library’s Pharmacotherapy First: A Multimedia Learning Resource. Washington, DC: American Pharmacists Association; 2019.
- Kale-Pradhan P, Wilhelm S, McConachie S. Nausea and Vomiting. Pharmacy Library’s Pharmacotherapy First: A Multimedia Learning Resource. Washington, DC: American Pharmacists Association; 2019.
- Wilhelm S, McConachie S, Kale-Pradhan P. Diarrhea, Constipation, and Irritable Bowel Syndrome. Pharmacy Library’s Pharmacotherapy First: A Multimedia Learning Resource. Washington, DC: American Pharmacists Association; 2019.
Refereed Journals
- August BA, and Kale-Pradhan PB. Management of Invasive Candidiasis: A Focus on Rezafungin, Ibrexafungerp, and Fosmanogepix (Accepted for publication by Pharmacotherapy)
- Martirosov AL, Giuliano C, Shupp M, Channey S, Kale-Pradhan PB. Zavegepant Intranasal Spray for Migraines. Annals of Pharmacotherapy. 2023;0(0).
- August BA, Matlob A and Kale-Pradhan PB. Sulbactam-Durlobactam. Ann Pharmacother. 2023 Oct 10:10600280231204566.
- Kale-Pradhan PB, Pacitto R, Giuliano CA and Johnson LB. Evaluation of the Effect of High-Dose versus Standard-Dose Dexamethasone on Mortality Among Mechanically Ventilated COVID-19 Patients Current Drug Safety 2023 Aug 17. doi: 10.2174/1574886318666230817102043. Epub ahead of print. PMID: 37592771
- Lobkovich A, Kale-Pradhan P, Lipari M. Incretin Analogs for Weight Management in Adults Without Diabetes. Annals of Pharmacotherapy. 2023;0(0).
- Martirosov AL, Doane A, Patel R, Aprilliano B, George J, Kale-Pradhan PB. Podcasts and Videos and Slides... Oh My!: Traditional vs Nontraditional Teaching Methods in a Remote Classroom Setting. Currents in Pharmacy Teaching and Learning 2023. (Manuscript accepted for publication).
- August BA, Kale-Pradhan PB, Giuliano CA and Johnson LB. Biomarkers in the Intensive Care Setting: A Focus on using Procalcitonin and C- Reactive Protein to Optimize Antimicrobial Duration of Therapy Pharmacotherapy 2023 (Manuscript accepted for publication)
- Aprilliano B, Giuliano C, Reed JB and Kale-Pradhan PB. Evaluation of References Supporting Hospital Pharmacy Policies. Medical Refence Services Quarterly 2023;42(1):31-37. DOI: 10.1080/02763869.2023.2160119
- Lim L, Lipari M, Kale-Pradhan P. Intranasal Olopatadine: Mometasone in the Treatment of Seasonal Allergic Rhinitis. Ann Pharmacother. 2022 Sep 19:10600280221124230. doi: 10.1177/10600280221124230. Epub ahead of print. PMID: 36123818.
- Fiest J, Lipari M and Kale-Pradhan PB. Tezepelumab in the Treatment of Uncontrolled Severe Asthma. Annals of Pharmacotherapy 2022 (Accepted for Publication) Role: I am a senior author and was invited to write this review.
- Baalbaki N, Giuliano CA, Hartner CL, Kale-Pradhan PB, and Johnson LB. Azithromycin versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD. Journal of General Internal Medicine 2022 Mar 22:1–6. doi: 10.1007/s11606-022-07486-5. Epub ahead of print. PMID: 35316516; PMCID: PMC8939242
- Berti AD, Kale-Pradhan PB, Giuliano CA, Aprilliano B, Miller CR, Alyashaea BT, Bhargava A and Johnson LB. Clinical Outcomes of Zinc Supplementation Among COVID-19 Patients. Current Drug Safety. 2022 Mar 17. doi: 10.2174/1574886317666220317115023. Online ahead of print.
- Berlie HD, Kale-Pradhan PB, Orzechowski, T and Jaber, LA. Mechanisms and potential roles of glucose-lowering agents in COVID-19: A Review. Ann Pharmacother 2021 Mar 4:1060028021999473. doi: 10.1177/1060028021999473. Epub ahead of print. PMID: 33657863.
- Kale-Pradhan PB, Giuliano CA, Jongekrijg A and Rybak MA. Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics – A Meta-analysis – A Meta‐analysis. Pharmacotherapy 2020;40(7):648–658 doi: 10.1002/phar.2437.
- Lipari M, Kale-Pradhan PB and Wilhelm, Sheila. Dual– Versus Mono–Bronchodilator Therapy in Moderate to Severe COPD: A Meta-analysis. Ann Pharmacother 2020; 54(12):1232-1242 106002802093213. 10.1177/1060028020932134.
- McConachie SM1, Giuliano CA, Mohammad I, Kale-Pradhan PB. Adverse drug reactions in drug information databases: does presentation affect interpretation? J Med Libr Assoc. 2020 Jan;108(1):76-83. doi: 10.5195/jmla.2020.748. Epub 2020 Jan 1.
- Neu R, Leonard MA, Dehoorne ML, Scalia SJ, Kale-Pradhan PB, Giuliano CA. Impact of Pharmacist Involvement in Heart Failure Transition of Care. Ann Pharmacother. 2019 Oct 11:1060028019882685. doi: 10.1177/1060028019882685.
- McConachie SM, Caputo RA, Wilhelm SM, and Kale-Pradhan PB. Efficacy of Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review. Ann of Pharmacother 2019;53(11):1145-1152. doi: 10.1177/1060028019852601.
- Giuliano CA, Patel C, Kale-Pradhan PB. A Guide to Bacterial Culture Identification and Result Interpretation. P & T: A Peer-Reviewed Journal for Formulary Management 2019;44(4):192-200.
- Sharma, M., Braekevelt, K., Kale-Pradhan, P., Szpunar, S., & Khatib, R. Are Blacks at Higher Risk for Vancomycin-Related Acute Kidney Injury? Journal of Pharmacy Practice. 2019 Jan 22:1-6 https://doi.org/10.1177/0897190018800093.
Abstracts Published in Academic Journals
- Kale-Pradhan P., Lim L, Graskewicz H, Malviya M, Coyle M, Giuliano C, and Johnson LB, Clinical and Drug Resistance Characteristics of Providencia spp. Infections (Abstract 579). Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.648, https://doi.org/10.1093/ofid/ofad500.648 Presented at ID Week October 2023, Boston, MA
- Kale-Pradhan P., Lim L, Graskewicz H, Malviya M, Coyle M, Giuliano C, and Johnson LB, Clinical and Drug Resistance Characteristics of Providencia spp. Infections. Presented at Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University Research Day October 2023.
- Kue K., Kale-Pradhan PB, Marshall MB, Giuliano CA and Johnson LB. Outcomes of Bacteremic Patients with Molecular Rapid Diagnostic Test Results. Presented at ASHP Mid -Year Clinical Meeting December 2022 Las Vegas NV
- Feist J, Panecaldo N, Kale-Pradhan PB, Delgado G, Giuliano CA, and Johnson LB. Prescribing Patterns of Skin and Soft Tissue Infections in Patients Discharged from the Emergency Department. Open Forum Infectious Diseases, 2022;9(Suppl 2), ofac492.1215.
- Tan J, Kue K, Kale-Pradhan PB, Delgado G, Giuliano CA, and Johnson LB. Prescribing Patterns of Urinary Tract Infections in Patients Discharged from the Emergency Department. Open Forum Infectious Diseases, 2022;9(Suppl 2), ofac492.1862.
- Kale-Pradhan PB, Pharm.D., Pacitto R, Krumm L, Hejnar A, Giuliano CA, and Johnson LB. Effect of High-Dose versus Standard-Dose Dexamethasone on Mortality Among Mechanically Ventilated COVID-19 Patients. Open Forum Infectious Diseases, 2022;9: (Suppl_2), ofac492.963.
- Marshall MB, Kale-Pradhan PB, Hejnar A, Smith E, Giuliano CA, Harriott M, Priziola J, and Johnson LB. When rapid molecular blood culture testing fails to identify the organism: microbiology and patient outcomes. Open Forum Infectious Diseases, 2022;9: (Suppl 2), ofac492.280.
- Kue K., Kale-Pradhan PB, Marshall MB, Giuliano CA and Johnson LB. Outcomes of Bacteremic Patients with Molecular Rapid Diagnostic Test Results. Presented at ASHP Mid-Year Clinical Meeting December 2022 Las Vegas NV
- Lim LD, Sorochak N, Giuliano CA, Kale-Pradhan PB, and Dehoorne M. Equitable Distribution of Monoclonal Antibodies for the Treatment of COVID-19. Presented at Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University Research Day October 2022. This project received first place in the PharmD Candidates category.
- Zoma L, Tsui A, Forman J and Kale-Pradhan PB. Evaluation of the Use of Growth Factors for the Treatment of Febrile Neutropenia in Oncology Patients. Presented at ASHP Midyear Clinical Meeting Dec 2021.
- Pacitto R, Krumm L, Hejnar A, Kale-Pradhan PB, Giuliano C, and Johnson L. Evaluation of the Effect of High-Dose versus Standard-Dose Dexamethasone on Mortality Among Mechanically Ventilated COVID-19 Patients: A Preliminary Report. Poster Presented at Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University Research Day October 2021. This project received ‘Honorable Mention (fourth place)’ in the PharmD Candidates category.
- Feist J, Panecaldo N, Kale-Pradhan PB, Delgado Jr G, Giuliano C Johnson L. Prescribing Patterns of SSTI Infections in Patients Discharged from the ED. Poster Presented at Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University Research Day October 2021
- Tan YJ, Kue K, Kale-Pradhan PB, Giuliano C, Delgado Jr G, and Johnson L. Prescribing Patterns for Urinary Tract Infections in Patients Discharged from the Emergency Department Presented at Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University Research Day October 2021
- Kale-Pradhan PB, Baalbaki N, Aprilliano, B, Giuliano C, Hartner C, Johnson LB. Azithromycin vs Beta Lactams in Acute Exacerbations of COPD. Poster presented at ID week 2021 Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Page S737, https://doi.org/10.1093/ofid/ofab466.1489 (Abstract # 1056130).
- Berti A, Kale-Pradhan PB, Giuliano CA, Aprilliano B, Miller C, Bhargava A and Johnson LB. Evaluation of Hydroxychloroquine-based Combination Therapies for the Treatment of COVID-19. Poster presented at ID week 2020 (Abstract # 910092)
- Kale-Pradhan PB, Manuel M and Johnson LB. Clinical Utility of Oseltamivir Restriction Policy. Poster presented at ID week 2020 (Abstract # 893985)
- Jongekrijg A, George J, Kale-Pradhan PB, Johnson LB. Effect of Treatment Duration on Outcomes in Septic Patients Admitted for Urinary Tract Infections from Extended Care Facilities. Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Pages S536–S537, https://doi.org/10.1093/ofid/ofz360.1333 (Abstract #1469)
- George J, Kale-Pradhan PB, Johnson LB. Outcomes of Patients with Positive Procalcitonin Levels Who Do Not Receive Continued Antibiotics. Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Page S674, https://doi.org/10.1093/ofid/ofz360.168